MIP and ocular melanoma: The key characteristics of MIP are that 1) anti-MIP antibodies that bind to the surfaces of pathogenic gonococci and meningococci are bactericidal, and 2) it may offer an OM-located drug target to help treat infections caused by antibiotic-resistant gonococci.